Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other Non-Current Liabilities (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Other Non-Current Liabilities data on record, last reported at $2.0 million in Q3 2012.

  • For Q3 2012, Other Non-Current Liabilities rose 8.46% year-over-year to $2.0 million; the TTM value through Sep 2012 reached $2.0 million, up 8.46%, while the annual FY2012 figure was $2.0 million, 166.67% up from the prior year.
  • Other Non-Current Liabilities reached $2.0 million in Q3 2012 per SNOA's latest filing, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.0 million in Q4 2011 and bottomed at $750000.0 in Q1 2011.